share_log

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga Real-time News ·  Nov 22, 2022 08:08

Gainers

  • OncoSec Medical (NASDAQ:ONCS) shares rose 31.9% to $6.4 during Tuesday's pre-market session. The market value of their outstanding shares is at $11.4 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) shares rose 20.61% to $0.58. The market value of their outstanding shares is at $7.5 million.
  • BrainsWay (NASDAQ:BWAY) shares moved upwards by 17.8% to $2.25. The company's market cap stands at $37.1 million. As per the news, the Q3 earnings report came out 4 days ago.
  • Cyclerion Therapeutics (NASDAQ:CYCN) shares moved upwards by 16.02% to $0.65. The company's market cap stands at $28.2 million.
  • Accelerate Diagnostics (NASDAQ:AXDX) stock increased by 13.03% to $1.04. The market value of their outstanding shares is at $103.0 million.
  • Marker Therapeutics (NASDAQ:MRKR) stock rose 12.08% to $0.37. The market value of their outstanding shares is at $30.9 million.

Losers

  • scPharmaceuticals (NASDAQ:SCPH) stock fell 15.1% to $5.17 during Tuesday's pre-market session. The market value of their outstanding shares is at $141.8 million.
  • Hillstream BioPharma (NASDAQ:HILS) stock fell 14.78% to $0.4. The market value of their outstanding shares is at $4.6 million.
  • Graybug Vision (NASDAQ:GRAY) stock fell 14.02% to $0.81. The company's market cap stands at $17.5 million.
  • Tenon Medical (NASDAQ:TNON) shares fell 10.17% to $2.65. The company's market cap stands at $29.7 million.
  • Minerva Surgical (NASDAQ:UTRS) stock decreased by 9.74% to $0.19. The company's market cap stands at $5.5 million.
  • NexImmune (NASDAQ:NEXI) shares decreased by 8.89% to $0.41. The company's market cap stands at $10.6 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment